Glioblastoma (GBM) is an aggressive brain tumor with a poor prognosis, but certain patients survive longer than average, possibly due to distinct molecular and clinical characteristics. Developing treatments targeting these unique features, such as IDH mutations and MGMT methylation, may improve outcomes. Immunotherapy and advanced imaging techniques also show promise for future treatment innovation.… Read More Understanding Glioblastoma for Effective Brain Cancer Treatment Strategies